ArticleBMC veterinary research2026
Construction of a reverse genetics and fluorescent reporter system for a bovine enterovirus isolated from cattle with diarrhea.
Article in BMC veterinary research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Development of a rapid antiviral screening assay based on GFP reporter virus of bovine enterovirus.Archives of virology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Bovine enteroviruses are widely detected in cattle, but molecular tools for functional studies and antiviral screening remain limited. In this study, a bovine enterovirus strain, GXHC2317, was isolated from diarrheic cattle in Hechi, Guangxi, China and propagated in BHK-21 cells. Full-genome sequencing and phylogenetic analyses classified GXHC2317 as Enterovirus E genotype 3, and recombination analyses indicated a mosaic genome with regions related to both northern and local Chinese lineages. To enable genetic manipulation, we constructed a full-length infectious cDNA clone of GXHC2317 under a CMV promoter and successfully rescued a recombinant virus, rGXHC2317, which showed replication kinetics comparable to the parental isolate in BHK-21 cells. Using an oral infection model in 4-week-old ICR mice, rGXHC2317 and GXHC2317 displayed similar tissue distribution and broadly comparable histopathology. Furthermore, we generated a fluorescent reporter virus by inserting UnaG at the 5′UTR–VP4 junction. The reporter virus produced clear cytopathic effects and strong fluorescence, although its peak titer was reduced compared with the parental strain. Finally, a fluorescence-based assay using rGXHC2317-UnaG enabled antiviral evaluation and distinguished inhibitory effects of ribavirin and pleconaril from the limited activity of chloroquine phosphate under our conditions. Together, these results provide a reverse genetics and fluorescent reporter platform for BEV that supports studies of viral biology and practical antiviral screening.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.